LEADER 01306nam 2200409 a 450 001 9910703087003321 005 20230902162158.0 035 $a(CKB)4950000000714906 035 $a(OCoLC)745006711 035 $a(EXLCZ)994950000000714906 100 $a20110804d2004 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAMT$b[electronic resource] 210 1$aJohnstown, PA :$cU.S. Dept. of Justice, National Drug Intelligence Center,$d[2004] 215 $a1 online resource (2 unnumbered pages) $ccolor illustrations 225 1 $aFast facts 225 1 $aQuestions and answers 300 $aTitle from title screen (viewed on Aug 4, 2011). 300 $a"NDIC product no. 2004-L0559-003." 410 0$aFast facts (National Drug Intelligence Center (U.S.)) 410 0$aQuestions and answers (National Drug Intelligence Center (U.S.)) 517 3 $aAlpha-methyltryptamine 606 $aTryptamine 606 $aDrug abuse$zUnited States 615 0$aTryptamine. 615 0$aDrug abuse 712 02$aNational Drug Intelligence Center (U.S.) 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910703087003321 996 $aAMT$93135048 997 $aUNINA